4′-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
US9708357B2 · kind B2 · utility
0Cited by
7References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2012 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | Sep 6, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of 3′-fluoro, 4′-azido nucleoside phosphoramidate prodrug derivatives of formula Iwherein the symbols are as defined in the specification, to pharmaceutically acceptable salts thereof, and to pharmaceutical compositions containing such compounds for the treatment of HCV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.